Periodontitis
Conditions
Interventions
Patients will receive 150mg of melinjo resveratrol for 4 weeks.
Patients will receive 150mg of placebo for 4 weeks.
Sponsors
Tokyo Medical and Dental University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Mild periodontitis patients;(2) Never had a periodontitis treatment before; (3) Non-smoker; (4)Bleeding on probing 10-30%; (5) no use of systemic antibiotics or oral anti-microbial agents within the past six months;
Exclusion criteria
Exclusion criteria: (1)severe systemic disease; (2) pregnancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The following clinical parameters are recorded at each visit (baseline, week2, week4): (1) pocket depth(PD); (2) clinical attachment level (CAL); (3) bleeding on probing (BOP) | — |
Countries
Japan
Contacts
Public ContactYuichi Ikeda
Tokyo Medical and Dental University Department of Periodontology
Outcome results
None listed